Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
Security class unavailable · CUSIP: 46333X108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,038,097
- Percent of class
- 13.7900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-24-000413
- Form type
- SC 13G
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- Nov 04, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership